Efungumab
Efungumab is a monoclonal antibody with antifungal activity. Efungumab binds to HSP 90, preventing a conformational change needed for fungal viability. Efungumab can be used for research on invasive candidiasis (IC) [1].
Product Specifications
CAS Number
762260-74-2
UNSPSC
12352203
Target
Fungal
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/efungumab.html
Solubility
H2O
Smiles
[Efungumab]
References & Citations
[1]Karwa R, et al. Efungumab: a novel agent in the treatment of invasive candidiasis. Ann Pharmacother. 2009 Nov;43 (11) :1818-23.|[2]Cowen LE, et al. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci U S A. 2009 Feb 24;106 (8) :2818-23.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15375272 1 Vial
Lentiviral human FAM9B sgRNA gene knockout kit - Lentiviral human FAM9B sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details 
247277-ML405 100 µL
HSF4 (Heat Shock Transcription Factor 4, CTM) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
